Bioactivity:

TA-1887 is a new type of selective inhibitor of sglt2 for the treatment of type 2 diabetes. It has a significant hypoglycemic effect in KK (HF-KK) mice fed a high-fat diet. TA-1887 has good pharmacokinetic characteristics and significantly increases UGE

CAS nr:

1003005-29-5

Purity:

98%

Molecular Weight:

427,47

SMILES:

O[C@H]1[C@H](N2C=C(CC3=CC=C(C4CC4)C=C3)C5=C2C=CC=C5F)O[C@H](CO)[C@@H](O)[C@@H]1O

Formula:

C24H26FNO5

Pathway:

Target: